Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Subramaniam, B.
Right arrow Articles by Shende, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subramaniam, B.
Right arrow Articles by Shende, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2001, Vol. 86, No. 1 84-89
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia

Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair

B. Subramaniam1, R. Madan2, S. Sadhasivam1, B. Sennaraj2, P. Tamilselvan3, S. Rajeshwari2, D. Jagan2 and D. Shende2

Department of Anaesthesiology and Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110 029, India. 1Beth Israel Deaconess Medical Centre, Boston, MA02215, USA. 2All India Institute of Medical Sciences, New Delhi, India. 3Bedford General Hospital, Bedfordshire, UK*Corresponding author

This study evaluated the antiemetic efficacy, cost-effectiveness and clinical utility of prophylactic ondansetron and dexamethasone compared with placebo in the prevention of postoperative nausea and vomiting (PONV) in 135 children (2–15 yr, ASA I–II) undergoing strabismus repair. After induction with halothane and nitrous oxide in oxygen or i.v. thiopental, the children received i.v. dexamethasone 1 mg kg–1 to a maximum of 25 mg, ondansetron 100 µg kg–1 to a maximum of 4 mg or placebo (n=45). Episodes of PONV were recorded for the first 24 h after the operation. True outcome measures (parental satisfaction score, duration of stay in the postanaesthesia care unit and fast tracking time), therapeutic outcome measures (number needed to prevent (NNTP) PONV) and the cost to benefit a child with each drug were analysed. The incidence and severity of PONV in the first 24 h were significantly less in the dexamethasone and ondansetron groups than in the placebo group (P<0.05). The incidence (P=0.04) and severity (P=0.03) of PONV at the 6–24 h epoch were significantly less in the dexamethasone group than in the ondansetron group. Recovery time (P=0.07), fast tracking time (P=0.6), parental satisfaction scores (P=0.08) and NNTP PONV were comparable (NNTP=2) in both the ondansetron and the dexamethasone group. The cost to benefit a child with dexamethasone was approximately 22 times less than that of ondansetron.

Br J Anaesth 2001; 86: 84–9


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
R. Madan, A. Bhatia, S. Chakithandy, R. Subramaniam, G. Rammohan, S. Deshpande, M. Singh, and H. L. Kaul
Prophylactic Dexamethasone for Postoperative Nausea and Vomiting in Pediatric Strabismus Surgery: A Dose Ranging and Safety Evaluation Study
Anesth. Analg., June 1, 2005; 100(6): 1622 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Durmus, E. Karaaslan, E. Ozturk, M. Gulec, M. Iraz, N. Edali, and M. O. Ersoy
The Effects of Single-Dose Dexamethasone on Wound Healing in Rats
Anesth. Analg., November 1, 2003; 97(5): 1377 - 1380.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.